Advertisement

Topics

PubMed Journals Articles About "Damon Runyon Cancer Research Foundation" RSS

04:22 EST 16th December 2017 | BioPortfolio

Damon Runyon Cancer Research Foundation PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest Damon Runyon Cancer Research Foundation articles that have been published worldwide.

More Information about "Damon Runyon Cancer Research Foundation" on BioPortfolio

We have published hundreds of Damon Runyon Cancer Research Foundation news stories on BioPortfolio along with dozens of Damon Runyon Cancer Research Foundation Clinical Trials and PubMed Articles about Damon Runyon Cancer Research Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Damon Runyon Cancer Research Foundation Companies in our database. You can also find out about relevant Damon Runyon Cancer Research Foundation Drugs and Medications on this site too.

Showing "Damon Runyon Cancer Research Foundation" PubMed Articles 1–25 of 38,000+

Connecting cancer to its causes requires incorporation of effects on tissue microenvironments.

In a recent paper in Science, Tomasetti et al. present an expanded model for cancer risk, which they claim demonstrates the relative contribution of mutations caused by replication errors, environment and heredity. The foundation of this model is the theory that the overwhelming driver of cancer risk is mutations. This perspective will present experimental evidence and evolutionary theory to challenge the basis of this underlying theory. An argument will be presented that the mutation-centric model of canc...


AACR Cancer Progress Report 2017: Harnessing Research Discoveries to Save Lives.

Adherence to the World Cancer Research Fund/American Institute for Cancer Research recommendations and colorectal cancer risk.

The World Cancer Research Fund (WCRF) and the American Institute for Cancer Research (AICR) released in 2007 eight recommendations for cancer prevention on body fatness, diet and physical activity. Our aim is to evaluate the relation between adherence to these recommendations and colorectal cancer (CRC) risk.


Prioritizing Mental Health Research in Cancer Patients and Survivors.

The United States spends billions of dollars annually on cancer research. Historically, compared to other areas of cancer research, very little funding has been dedicated to mental health research in cancer patients and survivors. Previous studies have indicated that psychological disorders are common in patients with cancer and might have significant influence on overall morbidity and mortality. However, adequate data are lacking to better assess this influence and the potential benefits of interventions. ...

Research priorities in cancer cachexia: The University of Rochester Cancer Center NCI Community Oncology Research Program Research Base Symposium on Cancer Cachexia and Sarcopenia.

Cancer cachexia remains understudied and there are no standard treatments available despite the publication of an international consensus definition and the completion of several large phase III intervention trials in the past 6 years. In September 2015, The University of Rochester Cancer Center NCORP Research Base led a Symposium on Cancer Cachexia and Sarcopenia with goals of reviewing the state of the science, identifying knowledge gaps, and formulating research priorities in cancer cachexia through acti...

Charting the future of cancer health disparities research: A position statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute.

Clinical research activity of the French cancer cooperative network: Overview and perspectives.

The French Cancer Plan 2014-2019 stresses the importance of strengthening collaboration between all stakeholders involved in the fight against cancer, including cancer cooperative groups and intergroups. This survey aimed to describe the basics characteristics and clinical research activity among the Cancer Cooperative Groups (Groupes coopérateurs en oncologie). The second objective was to identify facilitators and barriers to their research activity.

Retraction: Polymorphisms of the CYP1B1 Gene as Risk Factors for Human Renal Cell Cancer.

Correction: A Phase II Trial of Abiraterone Combined with Dutasteride for Men with Metastatic Castration-Resistant Prostate Cancer.

Retraction: GRM1 is An Androgen-Regulated Gene and its Expression Correlates with Prostate Cancer Progression in Pre-Clinical Models.

Novel in vitro cancer models for optimizing anti-EGFR therapies.

Pre-clinical models, that are able to recapitulate the biology and pathology of the original individual cancer, are needed to better investigate mechanisms of response and resistance to anticancer therapies. In this respect, novel in vitro models for metastatic colorectal cancer could be of high value.

Pre-clinical studies in remote ischaemic conditioning: a solid foundation for on-going clinical research?

The Effect of Positive SWOG Treatment Trials on Survival of Patients With Cancer in the US Population.

Recently, tremendous prominence has been given to the investigation of the effect of different research processes as part of the Cancer Moonshot. More than half a century ago, the National Cancer Institute (NCI) established a network of publicly funded cancer cooperative research groups to systematically evaluate new treatments for efficacy and safety.

Dual Inhibition of PIK3C3 and FGFR as a New Therapeutic Approach to Treat Bladder Cancer.

MPT0L145 has been developed as a FGFR inhibitor exhibiting significant anti-bladder cancer activity in vitro and in vivo via promoting autophagy-dependent cell death. Here, we aim to elucidate the underlying mechanisms.

The Epigenomic Revolution in Breast Cancer: From Single-Gene to Genome-Wide Next-Generation Approaches.

From the first identification of aberrant DNA methylation in primary human tumors more than three decades ago, exponential progress in cancer epigenetics research has been made. For many years, cancer epigenetics studies relied on identification of DNA methylation and histone modifications at specific genes. These studies laid the foundation for the field and revealed the epigenetic alterations as hallmark of cancer, as well as the crucial role of epigenetic mechanisms in tumorigenesis. The introduction of ...

Resistance Mechanisms to AZD9291 and Rociletinib-Response.

Resistance Mechanisms to AZD9291 and Rociletinib-Letter.

Refining Immunotherapy Approvals.

mTOR Pathway Mutations and Response to Rapalogs in RCC-Letter.

Posttraumatic stress-related psychological functioning in adult survivors of childhood cancer.

The majority of research examining posttraumatic stress symptoms/disorder (PTSS/PTSD) among adult survivors of childhood cancer has been oriented to cancer, assuming that cancer has been the most traumatic experience in their lives. Whether that assumption is valid, and how it might impact assessment of PTSS, is unknown.

Highlights of This Issue.

Highlights of This Issue.

Highlights of This Issue.

Demystifying research: it's for everyone.

Sam Foster, Chief Nurse at Heart of England NHS Foundation Trust, explains how practical guidance is now available to help all nurses-including those starting their careers on the frontline-to contribute to research.

Kidney Function, Proteinuria, and Cancer Incidence: The Korean Heart Study.

Reported associations of estimated glomerular filtration rate (eGFR) with cancer risk are inconsistent, and data for the proteinuria-cancer relationship are sparse. We sought to quantify the associations of cancer incidence with eGFR and with proteinuria in a large population-based cohort.


Quick Search
Advertisement